Our one discordant case, which was designated as HER2-negative primary breast cancer with FNA-HER2 positive metastatic ALN before NAC, but as HER2-positive breast cancer after NAC, may support this hypothesis. This evidence concerns the gene ERBB2 and breast cancer.